Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial

Marianna Adamo; Sara Ariotti; F (Frederico) Costa; S Curello; A Moschovitis; T (Ton) de Vries; HD White; S Windecker; Marco Valgimigli

doi:10.1016/j.jcin.2016.05.031

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial

Marianna Adamo, Sara Ariotti, F (Frederico) Costa, S Curello, A Moschovitis, T (Ton) de Vries, HD White, S Windecker, Marco Valgimigli

Cardiology

Research output: Contribution to journal › Article › Academic

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1667-1676
Number of pages	10
Journal	JACC-Cardiovascular interventions
Volume	9
Issue number	16
DOIs	https://doi.org/10.1016/j.jcin.2016.05.031
Publication status	Published - 2016

Research programs

EMC COEUR-09

Access to Document

10.1016/j.jcin.2016.05.031

http://hdl.handle.net/1765/93715

Cite this

Adamo, M., Ariotti, S., Costa, F., Curello, S., Moschovitis, A., de Vries, T., White, HD., Windecker, S., & Valgimigli, M. (2016). Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial. JACC-Cardiovascular interventions, 9(16), 1667-1676. https://doi.org/10.1016/j.jcin.2016.05.031

@article{3c8a0d705f714a7aa77b7893ad0b4582,

title = "Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial",

author = "Marianna Adamo and Sara Ariotti and Costa, \{F (Frederico)\} and S Curello and A Moschovitis and \{de Vries\}, \{T (Ton)\} and HD White and S Windecker and Marco Valgimigli",

year = "2016",

doi = "10.1016/j.jcin.2016.05.031",

language = "Undefined/Unknown",

volume = "9",

pages = "1667--1676",

journal = "JACC-Cardiovascular interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "16",

}

Adamo, M, Ariotti, S, Costa, F, Curello, S, Moschovitis, A, de Vries, T, White, HD, Windecker, S & Valgimigli, M 2016, 'Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial', JACC-Cardiovascular interventions, vol. 9, no. 16, pp. 1667-1676. https://doi.org/10.1016/j.jcin.2016.05.031

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial. / Adamo, Marianna; Ariotti, Sara; Costa, F (Frederico) et al.
In: JACC-Cardiovascular interventions, Vol. 9, No. 16, 2016, p. 1667-1676.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial

AU - Adamo, Marianna

AU - Ariotti, Sara

AU - Costa, F (Frederico)

AU - Curello, S

AU - Moschovitis, A

AU - de Vries, T (Ton)

AU - White, HD

AU - Windecker, S

AU - Valgimigli, Marco

PY - 2016

Y1 - 2016

U2 - 10.1016/j.jcin.2016.05.031

DO - 10.1016/j.jcin.2016.05.031

M3 - Article

C2 - 27539685

SN - 1936-8798

VL - 9

SP - 1667

EP - 1676

JO - JACC-Cardiovascular interventions

JF - JACC-Cardiovascular interventions

IS - 16

ER -

Adamo M, Ariotti S, Costa F, Curello S, Moschovitis A, de Vries T et al. Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome A Post Hoc Analysis From the PRISM Trial. JACC-Cardiovascular interventions. 2016;9(16):1667-1676. doi: 10.1016/j.jcin.2016.05.031